FDA Asks GSK, Others For Data On Asthma Drugs
The FDA said in a statement Wednesday that it asked the drugmakers in January for information about controlled clinical studies conducted on the products, known as long-acting beta agonists.
The drugs the agency has requested information on are GlaxoSmithKline's Advair and Serevent, Novartis AG's Foradil, AstraZeneca's Symbicort, Mylan Inc.'s Perforomist and Sepracor Inc.'s Brovana.
The companies indicated...
To view the full article, register now.